Quantcast

Latest Cancer Research Stories

Disrupted Sleep Patterns May Accelerate Tumor Growth
2014-01-28 06:29:35

Brett Smith for redOrbit.com - Your Universe Online A new study from a team of American researchers has revealed that a disrupted sleep pattern can accelerate the progression of cancer. According to the team’s report published in the journal Cancer Research, fragmented sleep disrupts a cancer-fighting metabolic pathway – a disruption that could be mitigated through drug therapy. "It's not the tumor, it's the immune system," said study director Dr. David Gozal, chairman of...

2014-01-24 13:27:45

Dana-Farber Cancer Institute scientists have developed a mathematical model to predict how a patient's tumor is likely to behave and which of several possible treatments is most likely to be effective. Reporting in the journal Cell Reports, researchers combined several types of data from pre- and post-treatment biopsies of breast tumors to obtain a molecular picture of how the cancer evolved as a result of chemotherapy. "Better understanding of tumor evolution is key to improving the...

2014-01-18 23:04:08

In response to an article published by Medical Daily, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses how breast cancer cells, even after remission, have the ability to become brain cancer cells. New York, NY (PRWEB) January 18, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, discusses breast cancer cells and their ability to travel to the brain and become brain cancer cells through...

2014-01-16 23:25:47

The Chris Elliott Fund, a 501(c)3 non-profit, held their grand opening on January 3rd. The center welcomes brain tumor patients, caregivers and family members seeking one-on-one help to their center and services. Redmond, WA (PRWEB) January 16, 2014 The Chris Elliott Fund (CEF) announced the grand opening of their Patient Support Services Center, a space devoted to serving brain cancer and brain tumor patients, their families and caregivers. The open house and ribbon cutting was on...

2014-01-16 14:22:49

University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer. The research, which is published today (Thursday 16 January) in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been...

2014-01-15 12:21:36

BALTIMORE, Jan. 15, 2014 /PRNewswire/ -- The National Institute of Health ("NIH"), the nation's largest biomedical research institution, will utilize Curtis Bay Medical Waste Services (www.curtisbaymws.com) for the next 5 years through 2018, for all of NIH's medical waste transportation and processing services. Curtis Bay was selected based on its environmentally sustainable and reliable medical waste management services, along with its proven commitment to exceptional customer...

2014-01-13 08:29:57

CAMBRIDGE, Mass., Jan. 13, 2014 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that CRLX101 has achieved its primary efficacy endpoint in an ongoing single-arm Phase 2 monotherapy clinical trial in relapsed ovarian cancer. The ongoing open label Phase 2 monotherapy trial is being conducted at Massachusetts General Hospital and the affiliated Harvard teaching hospitals under the direction of principal investigator,...

2014-01-13 08:29:07

PHILADELPHIA, Jan. 13, 2014 /PRNewswire/ -- The American Association for Cancer Research (AACR) and Debbie's Dream Foundation: Curing Stomach Cancer (DDF) are pleased to announce a new fellowship opportunity in gastric cancer research. (Photo: http://photos.prnewswire.com/prnh/20140113/PH44438 ) The Debbie's Dream Foundation-AACR Gastric Cancer Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct gastric cancer research...

2014-01-13 08:28:33

The company's SnapPath® system facilitates personalized medicine MOUNTAIN VIEW, Calif., Jan. 13, 2014 /PRNewswire/ -- Based on its recent analysis of the cancer diagnostics market, Frost & Sullivan recognizes BioMarker Strategies LLC with the 2013 North American Frost & Sullivan Award for Technology Innovation Leadership. BioMarker Strategies has pioneered the development and validation of SnapPath®, a novel platform for live tumor cell processing and testing. This rapid, robust and...

2014-01-11 23:02:39

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org, discussing new research that has found a mechanism implicated in brain cancer and a drug that is proving to decrease brain tumor growth. New York, NY (PRWEB) January 11, 2014 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to an article published by EurekaAlert.org on January 1, 2014, that...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related